InvestorsObserver
×
News Home

Analyst Rating: Will Immunitybio Inc (IBRX) Stock Outperform the Market?

Thursday, July 08, 2021 02:52 PM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Immunitybio Inc (IBRX) Stock Outperform the Market?

Analysts who follow Immunitybio Inc (IBRX) on average expect it to increase 98.89% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.

That average rating earns the stock an Analyst Ranking of 75, which means it ranks higher than 75 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 5
Wall Street analysts are rating IBRX a Strong Buy today. Find out what this means to you and get the rest of the rankings on IBRX!

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.

InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Immunitybio Inc Stock Today?

Immunitybio Inc (IBRX) stock is trading at $12.57 as of 2:43 PM on Thursday, Jul 8, a decline of -$0.27, or -2.1% from the previous closing price of $12.84. The stock has traded between $11.88 and $12.82 so far today. Volume today is less active than usual. So far 509,063 shares have traded compared to average volume of 1,506,378 shares.

Click Here to get the full report on Immunitybio Inc (IBRX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App